The ligand binding profiles of estrogen receptors alpha and beta are species dependent

Heather A Harris1, Ashok R Bapat, Daniel S Gonder

  • 1Women's Health Research Institute, Wyeth-Ayerst Research, 500 Arcola Road, Radnor, PA 19087, USA. harrish@war.wyeth.com

Steroids
|April 18, 2002
PubMed

Insights

Ligand binding to estrogen receptors (ER-alpha and ER-beta) can differ between species. This species-dependent selectivity impacts the development of new menopause treatments and therapies.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Molecular Biology

Background:

  • Estrogens and selective estrogen receptor modulators (SERMs) are crucial for managing menopause-related conditions.
  • Estrogen receptors (ERs), specifically ER-alpha and ER-beta, mediate estrogenic activity through ligand binding.
  • Developing novel ER ligands requires understanding receptor-ligand interactions.

Purpose of the Study:

  • To investigate whether estrogen receptor subtype selectivity is consistent across different species.
  • To evaluate the species-specific binding profiles of various estrogens, steroids, phytoestrogens, and SERMs.
  • To identify potential reasons for observed species-dependent differences in ER ligand binding.

Main Methods:

  • Utilized a solid-phase radioligand binding assay.
  • Employed recombinant human, rat, and mouse ER-alpha and ER-beta proteins.
  • Tested a diverse panel of compounds including estrogens, steroids, phytoestrogens, and SERMs.

Main Results:

  • Observed significant species-dependent binding preferences for certain compounds towards ER-alpha or ER-beta.
  • Demonstrated that receptor subtype selectivity can vary based on the species of origin.
  • Crystallographic data revealed conserved amino acids in the ligand-binding cavity, suggesting other factors influence binding.

Conclusions:

  • The selectivity of a compound for a specific estrogen receptor subtype is not universal and can be species-dependent.
  • Species differences in ER ligand binding must be considered during the development of new ER-targeting therapeutics.
  • Further research is needed to elucidate the structural basis for species-dependent selectivity.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Internal Receptors01:56

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...